Sequence information
Variant position: 670 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 919 The length of the canonical sequence.
Location on the sequence:
FQAALGGNVPREQFTVVMLT
Y EREEVLMNSLERLNGLPYLN
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human FQAALGGNVPREQFTVVMLTY EREEVLMNSLERLNGLPYLN
Mouse FQAALGGNVQREQFTVVMLTY EREEVLMNSLERLNGLPYLN
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
1 – 919
Exostosin-like 3
Topological domain
52 – 919
Lumenal
Literature citations
Mutations in EXTL3 cause neuro-immuno-skeletal dysplasia syndrome.
Oud M.M.; Tuijnenburg P.; Hempel M.; van Vlies N.; Ren Z.; Ferdinandusse S.; Jansen M.H.; Santer R.; Johannsen J.; Bacchelli C.; Alders M.; Li R.; Davies R.; Dupuis L.; Cale C.M.; Wanders R.J.; Pals S.T.; Ocaka L.; James C.; Mueller I.; Lehmberg K.; Strom T.; Engels H.; Williams H.J.; Beales P.; Roepman R.; Dias P.; Brunner H.G.; Cobben J.M.; Hall C.; Hartley T.; Le Quesne Stabej P.; Mendoza-Londono R.; Davies E.G.; de Sousa S.B.; Lessel D.; Arts H.H.; Kuijpers T.W.;
Am. J. Hum. Genet. 100:281-296(2017)
Cited for: FUNCTION; CATALYTIC ACTIVITY; PATHWAY; SUBCELLULAR LOCATION; INVOLVEMENT IN ISDNA; VARIANTS ISDNA LEU-461; CYS-513; SER-657 AND ASP-670; CHARACTERIZATION OF VARIANTS ISDNA LEU-461; CYS-513; SER-657 AND ASP-670; VARIANT LEU-442;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.